Catalyst Wire Dossier Catalyst Wire Dossier

Lisraya

brepocitinib
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Lisraya. Get the full timeline:

Most recent: FDA Approves First Oral Drug Indicated to Treat Dermatomyositis in Adults

See pricing